T-Net2h
Eupraxia's DiffuSphere Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for Period of More Than Six Months
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, unveiled new pharmacokinetic ("PK") data from its Phase 2a Eosinophilic Esophagitis ("EoE") program.
T-Net3h
Ekona Receives $590,000 CICE Funding for Carbon Management Project
The BC Centre for Innovation and Clean Energy (CICE) is investing $590,000 in Burnaby-based Ekona Power as part of a recent $4.2 million investment in seven BC climate tech companies, selected from 79 ...
T-Net19h
General Fusion Confirms 'Significant Fusion Neutron Yield' and 'Plasma Stability' During MTF Compression Experiment Series
Scientific results demonstrate the company's achievements in creating fusion through MTF, providing foundation for its LM26 fusion demonstration, which will begin compressing large-scale plasmas in ...
T-Net22h
WELL Health Technologies Completes Acquisition of Jack Nathan Health's Canadian Clinical Assets, Begins to Operate Clinics at Wal-Mart
WELL Health Technologies Completes Acquisition of Jack Nathan Health's Canadian Clinical Assets Begins to Operate Clinics at ...
T-Net23h
Burnaby-based Svante Technologies Announces Strategic Investment from InBC
Svante Technologies, a leading global carbon capture and removal solutions provider headquartered in British Columbia, Canada ...